Guidance

Pneumococcal infant vaccination: information for healthcare practitioners

Information for healthcare practitioners on the changes to the infant pneumococcal vaccination schedule.

• From: UK Health Security Agency
• Published: 13 December 2019
• Last updated: 16 December 2025
  Show all updates

  1. 16 December 2025

     Version 03.00, updated with information on PCV14

  2. 2 June 2025

     Updated to reflect changes to the childhood immunisation schedule from 01 July 2025 with new HTML document.

  3. 23 July 2020

     Revised guidance and a reminder about the one-year booster dose.

  4. 13 December 2019

     First published.

Applies to England

Documents

Changes to the infant pneumococcal conjugate vaccine schedule: information for healthcare practitioners

HTML

Details

The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.

Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.

From 1 July 2025 the PCV13 immunisation schedule has been changed as follows:

• infants born on or after 30 June 2024 will be offered their first dose of PCV13 at 16 weeks of age to accommodate changes to routine childhood immunisation programme that move the first dose of MenB vaccine to 12 weeks

The one-year booster dose should be given regardless of the number of doses given under one year of age.